Literature DB >> 6104081

The Australian therapeutic trial in mild hypertension. Report by the Management Committee.

.   

Abstract

Entities:  

Mesh：

Year:  1980        PMID： 6104081

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   202.731


× No keyword cloud information.
  136 in total

Review 1.  Pathogenesis and pathology of coronary heart disease syndromes.

Authors:  P M Ridker; E M Antman
Journal:  J Thromb Thrombolysis       Date:  1999-10       Impact factor: 2.300

Review 2.  Is blood pressure reduction a valid surrogate endpoint for stroke prevention? An analysis incorporating a systematic review of randomised controlled trials, a by-trial weighted errors-in-variables regression, the surrogate threshold effect (STE) and the Biomarker-Surrogacy (BioSurrogate) Evaluation Schema (BSES).

Authors:  Marissa N Lassere; Kent R Johnson; Michal Schiff; David Rees
Journal:  BMC Med Res Methodol       Date:  2012-03-12       Impact factor: 4.615

Review 3.  Risks versus benefits of withdrawing antihypertensive therapy.

Authors:  H P Schobel; R E Schmieder; F H Messerli
Journal:  Drug Saf       Date:  1992 Nov-Dec       Impact factor: 5.606

Review 4.  Is hypertension in the elderly over-treated?

Authors:  B Lernfelt; S Landahl
Journal:  Drugs Aging       Date:  1992 Nov-Dec       Impact factor: 3.923

5.  Cardiovascular risk management of hypertension and hypercholesterolaemia in the Netherlands: from unifactorial to multifactorial approach.

Authors:  I van Dis; J M Geleijnse; W M M Verschuren; D Kromhout
Journal:  Neth Heart J       Date:  2012-08       Impact factor: 2.380

Review 6.  Newer beta blockers and the treatment of hypertension.

Authors:  D McAreavey; R Vermeulen; J I Robertson
Journal:  Cardiovasc Drugs Ther       Date:  1991-06       Impact factor: 3.727

7.  Effects of once daily indapamide and pindolol on blood pressure, plasma aldosterone concentration and plasma renin activity in a general practice setting.

Authors:  J P Chalmers; L M Wing; J J Grygiel; M J West; J R Graham; A J Bune
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

8.  Comparison of a lifestyle modification program with propranolol use in the management of diastolic hypertension.

Authors:  E J Pérez-Stable; T J Coates; R B Baron; B S Biró; W W Hauck; K S McHenry; P S Gardiner; D Feigal
Journal:  J Gen Intern Med       Date:  1995-08       Impact factor: 5.128

Review 9.  Treatment of hypertension based on both systolic and diastolic pressure could influence the cost of therapy.

Authors:  M Safar
Journal:  Cardiovasc Drugs Ther       Date:  1989-12       Impact factor: 3.727

10.  The Importance of Systolic Blood Pressure Control and Cardiovascular Disease Prevention.

Authors:  Jan N. Basile
Journal:  Curr Treat Options Cardiovasc Med       Date:  2003-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.